Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1

Cardiovascular Pathology

Volumn 24, Issue 3, 2015, Pages 160-167

  Swager, Sarah A ^a   Delfín, Dawn A ^a,c   Rastogi, Neha ^a,b   Wang, Honglan ^a,b   Canan, Benjamin D ^a,b   Fedorov, Vadim V ^a,b   Mohler, Peter J ^a,b   Kilic, Ahmet ^a   Higgins, Robert S D ^a   Ziolo, Mark T ^a,b   Janssen, Paul M L ^a,b   Rafael Fortney, Jill A ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Clinical and Translational Sciences Center KL2   (United States)

Author keywords

Cell junctions; Claudin 5; Ephrin B1; Heart failure; Human heart explants; Human myocardium

Indexed keywords

CD31 ANTIGEN; CLAUDIN 5; EPHRIN B1; CLDN5 PROTEIN, HUMAN; EFNB1 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELLS BY BODY ANATOMY; COMPARATIVE STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE CONTROL; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; CARDIAC MUSCLE CELL; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MIDDLE AGED;

ADULT; AGED; BLOTTING, WESTERN; CLAUDIN-5; ENDOTHELIAL CELLS; EPHRIN-B1; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC;

EID: 84929081483     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.10.006     Document Type: Article

References (25)

1. CW Yancy, M Jessup, B Bozkurt, J Butler, DE Casey, and MH Drazner et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 e240 e327
2. DA Delfin, KE Zang, KE Schill, NT Patel, PM Janssen, and SV Raman et al. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases Neuromuscul Disord 22 2012 1006 1014
3. TA Hainsey, S Senapati, DE Kuhn, and JA Rafael Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature Neuromuscul Disord 13 2003 294 302
4. PM Janssen, N Hiranandani, TA Mays, and JA Rafael-Fortney Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice Am J Physiol Heart Circ Physiol 289 2005 H2373 H2378
5. JL Sanford, JD Edwards, TA Mays, B Gong, AP Merriam, and JA Rafael-Fortney Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice J Mol Cell Cardiol 38 2005 323 332
6. DA Delfin, Y Xu, KE Schill, TA Mays, BD Canan, and KE Zang et al. Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model Mol Ther 20 2012 1378 1383
7. TA Mays, PF Binkley, A Lesinski, AA Doshi, MP Quaile, and KB Margulies et al. Claudin-5 levels are reduced in human end-stage cardiomyopathy J Mol Cell Cardiol 45 2008 81 87
8. E Dupont, T Matsushita, RA Kaba, C Vozzi, SR Coppen, and N Khan et al. Altered connexin expression in human congestive heart failure J Mol Cell Cardiol 33 2001 359 371
9. M Vatta, SJ Stetson, A Perez-Verdia, ML Entman, GP Noon, and G Torre-Amione et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy Lancet 359 2002 936 941
10. CA Koczor, EK Lee, RA Torres, A Boyd, JD Vega, and K Uppal et al. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis Physiol Genomics 45 2013 597 605
11. K Morita, H Sasaki, M Furuse, and S Tsukita Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells J Cell Biol 147 1999 185 194
12. G Genet, C Guilbeau-Frugier, B Honton, E Dague, MD Schneider, and C Coatrieux et al. Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion Circ Res 110 2012 688 700
13. AW Boyd, PF Bartlett, and M Lackmann Therapeutic targeting of EPH receptors and their ligands Nat Rev Drug Discov 13 2014 39 62
14. N Milani-Nejad, and PM Janssen Small and large animal models in cardiac contraction research: advantages and disadvantages Pharmacol Ther 141 2014 235 249
15. PML Janssen, SE Lehnart, J Prestle, and G Hasenfuss Preservation of contractile characteristics of human myocardium in multi-day cell culture J Mol Cell Cardiol 31 1999 1419 1427
16. EI Rossman, RE Petre, KW Chaudhary, V Piacentino, PM Janssen, and JP Gaughan et al. Abnormal frequency-dependent responses represent the pathophysiologic signature of contractile failure in human myocardium J Mol Cell Cardiol 36 2004 33 42
17. MT Ziolo, LS Maier, V Piacentino, J Bossuyt, SR Houser, and DM Bers Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2 + transients Circulation 109 2004 1886 1891
18. MJ Kohr, H Wang, DG Wheeler, M Velayutham, JL Zweier, and MT Ziolo Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes Cardiovasc Res 77 2008 353 361
19. M Zhang, E Takimoto, DI Lee, CX Santos, T Nakamura, and S Hsu et al. Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling Circulation 126 2012 942 951
20. L Han, M Li, and X Liu Effects of long-term atorvastatin treatment on cardiac aging Exp Ther Med 6 2013 721 726
21. E Van Vliet, M Melis, JM Foidart, and W Van Ewijk Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody J Histochem Cytochem 34 1986 883 890
22. G Bergers, and S Song The role of pericytes in blood-vessel formation and maintenance Neuro Oncol 7 2005 452 464
23. JM Sinning, J Losch, K Walenta, M Bohm, G Nickenig, and N Werner Circulating CD31 +/Annexin V+microparticles correlate with cardiovascular outcomes Eur Heart J 32 2011 2034 2041
24. MJ Hunt, GM Aru, MR Hayden, CK Moore, BD Hoit, and SC Tyagi Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure Am J Physiol Lung Cell Mol Physiol 283 2002 L239 L245
25. R Schafer, D Abraham, P Paulus, R Blumer, M Grimm, and J Wojta et al. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy Circulation 108 2003 1585 1591